MAPT and Classical progressive supranuclear palsy: In contrast, Zhao et al. suggested that ApoE2 is associated with increased tau pathology relative to ApoE3 or ApoE4 in primary tauopathies such as progressive supranuclear palsy and corticobasal degeneration42.